A Multi-Center, Prospective, Randomized Trial Comparing the Effectiveness of Aurix Therapy to Usual and Customary Care in Stage II-IV Pressure Ulcers
Description:
Pressure ulcers (PUs) are a common problem in all patient care settings, especially long-term
acute care facilities and nursing homes. Aurix is a platelet-rich plasma gel used in the
treatment of non-healing chronic wounds. The results of Aurix to date when used to treat PUs
have been promising. The aim of this trial is to demonstrate the effectiveness of complete
wound healing in a prospective, open-label, randomized trial in which pressure ulcers will be
treated using Aurix and standard of care to determine time to heal at 16 weeks. Comparison
will be made to patients receiving undefined Usual and Customary Care in a 1:1 manner.
Condition:
Pressure Ulcer
Treatment:
Aurix
Start Date:
February 2015
Sponsor:
Nuo Therapeutics
For More Information:
https://clinicaltrials.gov/show/NCT02352467